CD8A and melanoma: Establishment of effective antigen-specific CD8+ T cells enabled preliminary clinical success of cancer vaccines, oncolytic viruses, adoptive cellular therapy, and checkpoint inhibitors in several cancers including melanoma, lung cancer, renal cell cancer, Hodgkin’s lymphoma, etc. [5,6,7].